The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.

about

Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case.

P2860

Q26777679-3339CB15-7F03-49AA-99A0-1C3532DA5028 Q28391040-68D98421-C979-4F08-8D66-09EE9E9DBEF1 Q39609944-0F4CEBCC-FC7E-4925-83B6-8430AF90C0F5

P2860

The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.

Item

http://www.wikidata.org/entity/Q39003096

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The novel thymidylate synthase ...... -small cell lung cancer cells.

@en

The novel thymidylate synthase inhibitor trifluorothymidine

@nl

type

Item

label

The novel thymidylate synthase ...... -small cell lung cancer cells.

@en

The novel thymidylate synthase inhibitor trifluorothymidine

@nl

prefLabel

The novel thymidylate synthase ...... -small cell lung cancer cells.

@en

The novel thymidylate synthase inhibitor trifluorothymidine

@nl

P1476

The novel thymidylate synthase ...... n-small cell lung cancer cells

@en

P2093

Godefridus J Peters

http://www.w3.org/2001/XMLSchema#string

Ingrid A M van Roosmalen

http://www.w3.org/2001/XMLSchema#string

Irene V Bijnsdorp

http://www.w3.org/2001/XMLSchema#string

Jorn Smit

http://www.w3.org/2001/XMLSchema#string

Kaamar Azijli

http://www.w3.org/2001/XMLSchema#string

Masakazu Fukushima

http://www.w3.org/2001/XMLSchema#string

Saravanan Pillai

http://www.w3.org/2001/XMLSchema#string

Steven de Jong

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor

Cell death: critical control points

Cell-cycle checkpoints and cancer

Cancer statistics, 2007

Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.

Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours.

Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

Cell death independent of caspases: a review.

Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.

P2888

s00280-014-2465-1

P304

1273-1283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-014-2465-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frank P Vleggaar

P577

2014-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261773155

http://www.w3.org/2001/XMLSchema#string

P698

24744163

http://www.w3.org/2001/XMLSchema#string

The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.

about

P2860

P2860

The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698